ReviewAnnals of clinical microbiology and antimicrobials2018
Mycetoma: a clinical dilemma in resource limited settings.
Review in Annals of clinical microbiology and antimicrobials, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed, 63 citations in OpenAlex.
- Eumycetoma Caused by Acremonium Species in a Farmer From Western Guatemala: A Case Report.Cureus · 2026Article
- Microsurgical reconstruction after foot eumycetoma excision: Description of two cases.JPRAS open · 2026Article
- Article
- Article
- Traditional healing and mycetoma management in East Sennar State (Sudan): a qualitative exploration.International journal for equity in health · 2025Article
- Advanced eumycetoma with intracranial extension in three Sudanese patients: a case series and review of the literature.Journal of medical case reports · 2025Review
- Identification of Microbial-Based Natural Products as Potential CYP51 Inhibitors for Eumycetoma Treatment: Insights from Molecular Docking, MM-GBSA Calculations, ADMET Analysis, and Molecular Dynamics Simulations.Pharmaceuticals (Basel, Switzerland) · 2025Article
- The First Autochthonous Case of Actinomycetoma in a Bedouin Patient in the Israeli Negev Region.The American journal of tropical medicine and hygiene · 2025Article
- A Longstanding Case of Black Grain Mycetoma in a Somalian Male Patient: A Case Report.Clinical case reports · 2025Article
- Comprehensive management of actinomycetoma in a young male: A case report from Somalia.IDCases · 2025Article
- Repurposing FDA-Approved Drugs for Eumycetoma Treatment: Homology Modeling and Computational Screening of CYP51 Inhibitors.International journal of molecular sciences · 2025Article
- A Rare Case of Actinomycetoma In Pregnancy: Effective Treatment with the Combination of Amoxicillin-Clavulanic Acid.International journal of women's health · 2025Article
- Community-Based Mycetoma Surveillance in Uganda: Identifying Knowledge Gaps and Training of Community Health Workers to Improve Case Detection.PLoS neglected tropical diseases · 2024Article
- Deep mycosis mimicking cutaneous squamous cell carcinoma.Dermatology reports · 2024Article
- Importance of clinico-pathologic correlation in rare, chronic infectious diseases: Actinomycetoma misdiagnosed as botryomycosis-A case report.Clinical case reports · 2024Article
- The utility ofFrontiers in immunology · 2024Review
- Social determinants of health as drivers of fungal disease.EClinicalMedicine · 2023Review
- Recurrent abdominal wall mass in a hepatitis B-positive male: An unusual case of lumbar mycetoma.Clinical case reports · 2023Article
- Unusual manifestation of cystic mycetoma lesions: A case report.Clinical case reports · 2023Article
- A scoping review of mycetoma profile in Egypt: revisiting the global endemicity map.Transactions of the Royal Society of Tropical Medicine and Hygiene · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMycetoma is a chronic mutilating disease of the skin and the underlying tissues caused by fungi or bacteria. Although recently included in the list of neglected tropical diseases by the World Health Organization, strategic control and preventive measures are yet to be outlined. Thus, it continues to pose huge public health threat in many tropical and sub-tropical countries. If not detected and managed early, it results into gruesome deformity of the limbs. Its low report and lack of familiarity may predispose patients to misdiagnosis and delayed treatment initiation. More so in situation where diagnostic tools are limited or unavailable, little or no option is left but to clinically diagnose these patients. Therefore, an overview of clinical course of mycetoma, a suggested diagnostic algorithm and proposed use of materials that cover the exposed susceptible parts of the body during labour may assist in the prevention and improvement of its management. Furthermore, early reporting which should be encouraged through formal and informal education and sensitization is strongly suggested. MAIN TEXT: An overview of the clinical presentation of mycetoma in the early and late phases, clues to distinguish eumycetoma from actinomycetoma in the field and the laboratory, differential diagnosis and a suggested diagnostic algorithm that may be useful in making diagnosis amidst the differential diagnosis of mycetoma is given. Additionally, a proposed preventive measures which may be helpful in the community is also provided. Since treatment is currently based on expert opinion, we encourage active research to establish treatment guideline for it.
conclusionSince delay in visiting health facility results into gruesome complication, early presentation, recognition and initiation of appropriate choice of regimen is helpful in reducing complications. The clinical overview of mycetoma and the suggested algorithm may enhance suspicion and possibly increase recognition of mycetoma in the community and further guide in differentiation of eumycetoma from actinomycetoma. There is an urgent need for research funding for mycetoma, a disease plagued by severe physical disabilities and social stigma leading to isolation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.